These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 28732866

  • 1. Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides.
    Hu G, Shao M, Gao X, Wang F, Liu C.
    Carbohydr Polym; 2017 Oct 01; 173():276-285. PubMed ID: 28732866
    [Abstract] [Full Text] [Related]

  • 2. Uncovering the detailed mode of cleavage of heparinase I toward structurally defined heparin oligosaccharides.
    Zhang C, Tang F, Zhang J, Cao J, Li H, Liu C.
    Int J Biol Macromol; 2019 Dec 01; 141():756-764. PubMed ID: 31479666
    [Abstract] [Full Text] [Related]

  • 3. Exploring bacterial heparinase II activities with defined substrates.
    Bohlmann L, Chang CW, Beacham I, von Itzstein M.
    Chembiochem; 2015 May 26; 16(8):1205-11. PubMed ID: 25907974
    [Abstract] [Full Text] [Related]

  • 4. Expanding the Catalytic Promiscuity of Heparinase III from Pedobacter heparinus.
    Gu Y, Lu M, Wang Z, Wu X, Chen Y.
    Chemistry; 2017 Feb 21; 23(11):2548-2551. PubMed ID: 28067452
    [Abstract] [Full Text] [Related]

  • 5. Examination of the substrate specificity of heparin and heparan sulfate lyases.
    Linhardt RJ, Turnbull JE, Wang HM, Loganathan D, Gallagher JT.
    Biochemistry; 1990 Mar 13; 29(10):2611-7. PubMed ID: 2334685
    [Abstract] [Full Text] [Related]

  • 6. Production of size-defined heparosan, heparan sulfate, and heparin oligosaccharides by enzymatic depolymerization.
    Brown S, Kuberan B.
    Methods Mol Biol; 2015 Mar 13; 1229():21-9. PubMed ID: 25325940
    [Abstract] [Full Text] [Related]

  • 7. Histidine 295 and histidine 510 are crucial for the enzymatic degradation of heparan sulfate by heparinase III.
    Pojasek K, Shriver Z, Hu Y, Sasisekharan R.
    Biochemistry; 2000 Apr 11; 39(14):4012-9. PubMed ID: 10747789
    [Abstract] [Full Text] [Related]

  • 8. Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate.
    Wei Z, Lyon M, Gallagher JT.
    J Biol Chem; 2005 Apr 22; 280(16):15742-8. PubMed ID: 15705564
    [Abstract] [Full Text] [Related]

  • 9. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
    Yamada S, Sakamoto K, Tsuda H, Yoshida K, Sugahara K, Khoo KH, Morris HR, Dell A.
    Glycobiology; 1994 Feb 22; 4(1):69-78. PubMed ID: 8186552
    [Abstract] [Full Text] [Related]

  • 10. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
    Hausser H, Kresse H.
    Biochem J; 1999 Dec 15; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
    [Abstract] [Full Text] [Related]

  • 11. Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides.
    Hileman RE, Smith AE, Toida T, Linhardt RJ.
    Glycobiology; 1997 Mar 15; 7(2):231-9. PubMed ID: 9134430
    [Abstract] [Full Text] [Related]

  • 12. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
    Desai UR, Wang HM, Linhardt RJ.
    Arch Biochem Biophys; 1993 Nov 01; 306(2):461-8. PubMed ID: 8215450
    [Abstract] [Full Text] [Related]

  • 13. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.
    Chai W, Leteux C, Westling C, Lindahl U, Feizi T.
    Biochemistry; 2004 Jul 06; 43(26):8590-9. PubMed ID: 15222770
    [Abstract] [Full Text] [Related]

  • 14. Influence of saccharide modifications on heparin lyase III substrate specificities.
    Wu J, Chopra P, Boons GJ, Zaia J.
    Glycobiology; 2022 Mar 30; 32(3):208-217. PubMed ID: 33822051
    [Abstract] [Full Text] [Related]

  • 15. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.
    Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT.
    J Biol Chem; 1998 Sep 04; 273(36):22936-42. PubMed ID: 9722514
    [Abstract] [Full Text] [Related]

  • 16. Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies.
    Wei Z, Deakin JA, Blaum BS, Uhrín D, Gallagher JT, Lyon M.
    Glycoconj J; 2011 Dec 04; 28(8-9):525-35. PubMed ID: 21948150
    [Abstract] [Full Text] [Related]

  • 17. Heparan sulfate, heparin, and heparinase activity detection on polyacrylamide gel electrophoresis using the fluorochrome tris(2,2'-bipyridine) ruthenium (II).
    Rozenberg GI, Espada J, de Cidre LL, Eiján AM, Calvo JC, Bertolesi GE.
    Electrophoresis; 2001 Jan 04; 22(1):3-11. PubMed ID: 11197174
    [Abstract] [Full Text] [Related]

  • 18. Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases.
    Rice KG, Linhardt RJ.
    Carbohydr Res; 1989 Jul 15; 190(2):219-33. PubMed ID: 2805009
    [Abstract] [Full Text] [Related]

  • 19. Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.
    Hsieh PH, Xu Y, Keire DA, Liu J.
    Glycobiology; 2014 Aug 15; 24(8):681-92. PubMed ID: 24770491
    [Abstract] [Full Text] [Related]

  • 20. A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.
    Murphy KJ, Merry CL, Lyon M, Thompson JE, Roberts IS, Gallagher JT.
    J Biol Chem; 2004 Jun 25; 279(26):27239-45. PubMed ID: 15047699
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.